|
gptkbp:instanceOf
|
LSD
amphetamine
Hallucinogen
|
|
gptkbp:CASNumber
|
1043868-97-8
|
|
gptkbp:category
|
Hallucinogen
recreational drug
|
|
gptkbp:chemicalFormula
|
C18H22BrNO3
|
|
gptkbp:discoveredBy
|
gptkb:Ralf_Heim
|
|
gptkbp:discoveredIn
|
2004
|
|
gptkbp:effect
|
euphoria
hallucinations
altered perception
stimulation
|
|
gptkbp:firstReported
|
2004
|
|
gptkbp:form
|
gptkb:water
powder
blotter paper
|
|
gptkbp:hasStreet
|
gptkb:Smiles
25B
N-Bomb
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
NBOMe-2C-B
|
|
gptkbp:IUPACName
|
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
|
|
gptkbp:legalStatus
|
gptkb:Class_A_(UK)
Schedule I (Canada)
Schedule I (USA)
|
|
gptkbp:mechanismOfAction
|
5-HT2A receptor agonist
serotonin receptor agonist
|
|
gptkbp:molecularWeight
|
380.28 g/mol
|
|
gptkbp:not_used_as
|
gptkb:medicine
|
|
gptkbp:otherName
|
gptkb:25B-NBOMe
2C-B-NBOMe
NBOMe-B
|
|
gptkbp:parent_compound
|
gptkb:2C-B
|
|
gptkbp:PubChem_CID
|
57458045
|
|
gptkbp:relatedTo
|
gptkb:25C-NBOMe
gptkb:25I-NBOMe
gptkb:2C-B
|
|
gptkbp:routeOfAdministration
|
insufflation
sublingual
buccal
|
|
gptkbp:smiles
|
COc1cc(CNCC2=CC=CC=C2OC)cc(Br)c1OC
|
|
gptkbp:toxicity
|
seizures
potentially dangerous
risk of overdose
vasoconstriction
death (in rare cases)
|
|
gptkbp:UNII
|
6J6J1I8A7V
|
|
gptkbp:usedFor
|
recreational drug
|
|
gptkbp:bfsParent
|
gptkb:2C-B-NBOMe-2,3-methylenedioxy
|
|
gptkbp:bfsLayer
|
7
|